Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 879 results
Sort by: relevance publication year
Showing results for ISSN matching 2059-0105

Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

JOURNAL ARTICLE published 6 November 2021 in npj Vaccines

Authors: Kevin O. Saunders | Norbert Pardi | Robert Parks | Sampa Santra | Zekun Mu | Laura Sutherland | Richard Scearce | Maggie Barr | Amanda Eaton | Giovanna Hernandez | Derrick Goodman | Michael J. Hogan | Istvan Tombacz | David N. Gordon | R. Wes Rountree | Yunfei Wang | Mark G. Lewis | Theodore C. Pierson | Chris Barbosa | Ying Tam | Gary R. Matyas | Mangala Rao | Zoltan Beck | Xiaoying Shen | Guido Ferrari | Georgia D. Tomaras | David C. Montefiori | Drew Weissman | Barton F. Haynes

https://doi.org/10.1038/s41541-021-00397-2 Actions

Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine

JOURNAL ARTICLE published 23 January 2023 in npj Vaccines

Authors: James Z. Deng | Nathan Kuster | Ashley Drumheller | Mingxiang Lin | Frances Ansbro | Milica Grozdanovic | Rachelle Samuel | Ping Zhuang

https://doi.org/10.1038/s41541-022-00584-9 Actions

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern

JOURNAL ARTICLE published 19 December 2022 in npj Vaccines

Research funded by U.S. Department of Health & Human Services | National Institutes of Health (R01AI139092,R01AI157975,R01AI137472,R01AI157975,R01AI139092,R01AI157975,R01AI139092)

Authors: Juan Shi | Gang Wang | Jian Zheng | Abhishek K. Verma | Xiaoqing Guan | Moffat M. Malisheni | Qibin Geng | Fang Li | Stanley Perlman | Lanying Du

https://doi.org/10.1038/s41541-022-00580-z Actions

Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2

JOURNAL ARTICLE published 28 June 2022 in npj Vaccines

Authors: Hong-Su Park | Yumiko Matsuoka | Cindy Luongo | Lijuan Yang | Celia Santos | Xueqiao Liu | Laura R. H. Ahlers | Ian N. Moore | Sharmin Afroz | Reed F. Johnson | Bernard A. P. Lafont | David W. Dorward | Elizabeth R. Fischer | Craig Martens | Siba K. Samal | Shirin Munir | Ursula J. Buchholz | Cyril Le Nouën

https://doi.org/10.1038/s41541-022-00493-x Actions

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

JOURNAL ARTICLE published 6 April 2024 in npj Vaccines

Research funded by Bill and Melinda Gates Foundation (OPP1111923,OPP1115782) | Aids Fonds (2016019) | European Molecular Biology Organization (STS-7814)

Authors: Iván del Moral-Sánchez | Edmund G. Wee | Yuejiao Xian | Wen-Hsin Lee | Joel D. Allen | Alba Torrents de la Peña | Rebeca Fróes Rocha | James Ferguson | André N. León | Sylvie Koekkoek | Edith E. Schermer | Judith A. Burger | Sanjeev Kumar | Robby Zwolsman | Mitch Brinkkemper | Aafke Aartse | Dirk Eggink | Julianna Han | Meng Yuan | Max Crispin | Gabriel Ozorowski | Andrew B. Ward | Ian A. Wilson | Tomáš Hanke | Kwinten Sliepen | Rogier W. Sanders

https://doi.org/10.1038/s41541-024-00862-8 Actions

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

JOURNAL ARTICLE published 13 August 2020 in npj Vaccines

Research funded by RCUK | Medical Research Council (MR/R005850/1)

Authors: Daniela P. Lage | Patrícia A. F. Ribeiro | Daniel S. Dias | Débora V. C. Mendonça | Fernanda F. Ramos | Lívia M. Carvalho | Daysiane de Oliveira | Bethina T. Steiner | Vívian T. Martins | Luísa Perin | Amanda S. Machado | Thaís T. O. Santos | Grasiele S. V. Tavares | João A. Oliveira-da-Silva | Jamil S. Oliveira | Bruno M. Roatt | Ricardo A. Machado-de-Ávila | Antônio L. Teixeira | Maria V. Humbert | Eduardo A. F. Coelho | Myron Christodoulides

https://doi.org/10.1038/s41541-020-00224-0 Actions

The road to approved vaccines for respiratory syncytial virus

JOURNAL ARTICLE published 25 September 2023 in npj Vaccines

Authors: Tracy J. Ruckwardt

https://doi.org/10.1038/s41541-023-00734-7 Actions

Recent advances in the production of recombinant glycoconjugate vaccines

JOURNAL ARTICLE published 1 May 2019 in npj Vaccines

Research funded by Wellcome Trust (102978/Z/13/Z,102978/Z/13/Z) | RCUK | Biotechnology and Biological Sciences Research Council (BB/N001591/1,BB/R008124/1,BB/N001591/1)

Authors: Emily Kay | Jon Cuccui | Brendan W. Wren

https://doi.org/10.1038/s41541-019-0110-z Actions

npj Vaccines

JOURNAL published

https://doi.org/10.1038/41541.2059-0105 Actions

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic

JOURNAL ARTICLE published 5 August 2021 in npj Vaccines

Authors: Samir Andrade Mendonça | Reka Lorincz | Paul Boucher | David T. Curiel

https://doi.org/10.1038/s41541-021-00356-x Actions

Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice

JOURNAL ARTICLE published 23 February 2023 in npj Vaccines

Authors: Sam Afkhami | Michael R. D’Agostino | Maryam Vaseghi-Shanjani | Madeleine Lepard | Jack X. Yang | Rocky Lai | Margaret Wa Yan Choi | Alexis Chacon | Anna Zganiacz | Kees L. M. C. Franken | Hildegund C. Ertl | Tom H. M. Ottenhoff | Mangalakumari Jeyanathan | Amy Gillgrass | Zhou Xing

https://doi.org/10.1038/s41541-023-00623-z Actions

Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells

JOURNAL ARTICLE published 6 September 2021 in npj Vaccines

Research funded by U.S. Department of Health & Human Services | National Institutes of Health (AI144462,AI144462,AI100663,AI142590,AI138963)

Authors: Jeong Hyun Lee | Laura Toy | Justin T. Kos | Yana Safonova | William R. Schief | Colin Havenar-Daughton | Corey T. Watson | Shane Crotty

https://doi.org/10.1038/s41541-021-00376-7 Actions

mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer

JOURNAL ARTICLE published 29 September 2023 in npj Vaccines

Authors: Ke Qiu | Xing Duan | Minzi Mao | Yao Song | Yufang Rao | Danni Cheng | Lan Feng | Xiuli Shao | Chuanhuan Jiang | Hai Huang | Yan Wang | Huifang Li | Xuemei Chen | Sisi Wu | Dan Luo | Fei Chen | Xingchen Peng | Yongbo Zheng | Haiyang Wang | Jun Liu | Yu Zhao | Xiangrong Song | Jianjun Ren

https://doi.org/10.1038/s41541-023-00733-8 Actions

Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine

JOURNAL ARTICLE published 28 February 2022 in npj Vaccines

Authors: Sung-Sil Moon | Marly Richter-Roche | Theresa K. Resch | Yuhuan Wang | Kimberly R. Foytich | Houping Wang | Bernardo A. Mainou | Winston Pewin | Jeongwoo Lee | Sebastien Henry | Devin V. McAllister | Baoming Jiang

https://doi.org/10.1038/s41541-022-00443-7 Actions

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

JOURNAL ARTICLE published 8 March 2022 in npj Vaccines

Authors: Kevin K. Ariën | Leo Heyndrickx | Johan Michiels | Katleen Vereecken | Kurt Van Lent | Sandra Coppens | Betty Willems | Pieter Pannus | Geert A. Martens | Marjan Van Esbroeck | Maria E. Goossens | Arnaud Marchant | Koen Bartholomeeusen | Isabelle Desombere

https://doi.org/10.1038/s41541-022-00459-z Actions

Rational development of a combined mRNA vaccine against COVID-19 and influenza

JOURNAL ARTICLE published 26 July 2022 in npj Vaccines

Authors: Qing Ye | Mei Wu | Chao Zhou | Xishan Lu | Baoying Huang | Ning Zhang | Hui Zhao | Hang Chi | Xiaojing Zhang | Dandan Ling | Rong-Rong Zhang | Zhuofan Li | Dan Luo | Yi-Jiao Huang | Hong-Ying Qiu | Haifeng Song | Wenjie Tan | Ke Xu | Bo Ying | Cheng-Feng Qin

https://doi.org/10.1038/s41541-022-00478-w Actions

Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines

JOURNAL ARTICLE published 10 December 2021 in npj Vaccines

Authors: Chakkumkal Anish | Michel Beurret | Jan Poolman

https://doi.org/10.1038/s41541-021-00409-1 Actions

A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle

JOURNAL ARTICLE published 18 August 2023 in npj Vaccines

Research funded by Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1ZIAAI001253,1ZIAAI001253,1ZIAAI001253,1ZIAAI001253,1ZIAAI001253,1ZIAAI001253,1ZIAAI001253)

Authors: Nichole D. Salinas | Rui Ma | Thayne H. Dickey | Holly McAleese | Tarik Ouahes | Carole A. Long | Kazutoyo Miura | Lynn E. Lambert | Niraj H. Tolia

https://doi.org/10.1038/s41541-023-00709-8 Actions

Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections

JOURNAL ARTICLE published 3 November 2020 in npj Vaccines

Authors: Jay Epstein | W. Martin Smid | Silvano Wendel | Daniel Somuah | Thierry Burnouf

https://doi.org/10.1038/s41541-020-00256-6 Actions

Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies

JOURNAL ARTICLE published 10 April 2024 in npj Vaccines

Authors: Yingying Hou | Min Chen | Yuan Bian | Yuan Hu | Junlan Chuan | Lei Zhong | Yuxuan Zhu | Rongsheng Tong

https://doi.org/10.1038/s41541-024-00874-4 Actions
Feedback: support@crossref.org